In various research centers around the world, there's a microscopic war raging: The one between constantly evolving bacteria and modern medicine. A recent breakthrough from Tel Aviv University may have given the latter a new edge.

Israeli Rosetta Green has signed a deal with the Bayer CropScience AG, a company that specializes in the production and commercialization of seeds. According to the agreement, Rosetta Green will produce hardier seeds that grow high-quality cotton in harsh environmental conditions, such as drought.

A 92-year-old scientist developed a kit that can detect the presence of bacteria resistant to antibiotics. The kit, which will be launched in Europe, also offers immediate information on the type of antibiotic that might still work.